Home Tags Cancer
La Trobe University’s Melbourne campus will soon become home to a new BioNTech facility that will manufacture new investigational mRNA therapies for serious diseases like cancer.
An international research team from the University of Waterloo has developed an innovative method that combines advanced bioprinting technologies with synthetic structures, such as microfluidic chips, to enhance 3D modelling of complex cancers.
Researchers at the University of Queensland (UQ) have identified a novel drug target that could potentially overcome drug resistance in cancer patients, thereby preventing tumour regrowth.
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.
Researchers at Peter MacCallum Cancer Centre are set to receive a $1 million grant from the Victorian government for the development of new mRNA treatments for various hard-to-treat cancers.
Walter and Eliza Hall of Medical Research (WEHI) has received a $900,000 grant from the Medical Research Future Fund for a research study that could produce a vaccine for patients with hard-to-treat cancers.
Australian biomedical company Inventia Life Science is the winner of the 2019 Good Design Award of the Year for its Rastrum 3D Bioprinter –...